Benzinga's Top Upgrades, Downgrades For December 21, 2017

Top Upgrades

  • Analysts at Bank of America upgraded Discovery Communications Inc. DISCA from Neutral to Buy. Discovery shares rose 1.88 percent to $22.79 in pre-market trading.
  • Buckingham upgraded JPMorgan Chase & Co. JPM from Neutral to Buy. JPMorgan shares rose 0.44 percent to $106.61 in pre-market trading.
  • Argus upgraded Darden Restaurants, Inc. DRI from Hold to Buy. Darden shares rose 0.50 percent to $96.15 in pre-market trading.
  • SunTrust Robinson Humphrey upgraded Park Hotels & Resorts Inc PK from Hold to Buy. Park Hotels shares rose 0.35 percent to close at $29.00 on Wednesday.
  • RBC Capital upgraded Coty Inc COTY from Sector Perform to Outperform. Coty shares gained 0.36 percent to close at $19.45 on Wednesday.
  • Analysts at Deutsche Bank upgraded Spirit Airlines Incorporated SAVE from Hold to Buy. Spirit Airlines shares rose 3.37 percent to $45.99 in pre-market trading.
  • Analysts at Wedbush upgraded Regions Financial Corp RF from Neutral to Outperform. Regions Financial shares fell 0.29 percent to close at $17.25 on Wednesday.
  • Buckingham upgraded Wells Fargo & Co WFC from Neutral to Buy. Wells Fargo shares slipped 0.36 percent to close at $60.14 on Wednesday.
  • Analysts at Deutsche Bank upgraded Allegiant Travel Company ALGT from Hold to Buy. Allegiant Travel shares fell 0.26 percent to close at $152.75 on Wednesday.


Top Downgrades

  • RBC Capital downgraded PG&E Corporation PCG from Outperform to Sector Perform. PG&E shares fell 11.58 percent to $45.20 in pre-market trading.
  • Analysts at Wedbush downgraded SunTrust Banks, Inc. STI from Outperform to Neutral. SunTrust shares fell 0.27 percent to close at $65.45 on Wednesday.
  • Jefferies downgraded Axovant Sciences Ltd AXON from Buy to Hold. Axovant Sciences shares fell 5.95 percent to $4.90 in pre-market trading.
  • Loop Capital downgraded Twenty-First Century Fox Inc FOXA from Hold to Sell. Twenty-First Century Fox shares fell 0.47 percent to $34.11 in pre-market trading.
  • Analysts at KLR Group downgraded Concho Resources Inc CXO from Buy to Hold. Concho Resources shares rose 0.13 percent to $147.00 in pre-market trading.
  • Buckingham downgraded Lazard Ltd LAZ from Buy to Neutral. Lazard fell 0.34 percent to $50.00 in pre-market trading.
  • Needham & Company downgraded Syntel, Inc. SYNT from Buy to Hold. Syntel shares fell 0.12 percent to close at $25.56 on Wednesday.


Top Initiations

  • KeyBanc initiated coverage on Regis Corporation RGS with a Sector Weight rating. Regis shares closed at $15.85 on Wednesday.
  • Stephens & Co. initiated coverage on Brooks Automation, Inc BRKS with an Overweight rating. The price target for Brooks Automation is set to $32. Brooks Automation shares closed at $24.68 on Wednesday.
  • H.C. Wainwright initiated coverage on La Jolla Pharmaceutical Company LJPC with a Buy rating. The price target for La Jolla Pharmaceutical is set to $62. La Jolla Pharmaceutical shares closed at $27.08 on Wednesday.
  • Analysts at Cowen & Co. initiated coverage on Mirati Therapeutics, Inc. MRTX with an Outperform rating. Mirati Therapeutics shares closed at $16.85 on Wednesday.
  • Analysts at B. Riley initiated coverage on Hasbro, Inc. HAS with a Buy rating. The price target for Hasbro is set to $108. Hasbro shares closed at $91.11 on Wednesday.
  • RBC Capital initiated coverage on Valley National Bancorp VLY with an Outperform rating. The price target for Valley National Bancorp is set to $14. Valley National Bancorp shares closed at $11.43 on Wednesday.
  • Analysts at KLR Group initiated coverage on Ring Energy Inc REI with a Buy rating. The price target for Ring Energy is set to $20. Ring Energy shares closed at $13.96 on Wednesday.
  • Analysts at Macquarie initiated coverage on Bright Horizons Family Solutions Inc BFAM with a Neutral rating. The price target for Bright Horizons Family is set to $95. Bright Horizons Family shares closed at $94.69 on Wednesday.
  • H.C. Wainwright initiated coverage on TrovaGene Inc TROV with a Buy rating. The price target for TrovaGene is set to $1. TrovaGene shares closed at $0.250 on Wednesday.
Posted In: BiotechnologyDowngradesHealth CareInitiationstop upgradesUpgradesDowngradesInitiationPre-Market OutlookAnalyst Ratings